The EMA will be delaying the roll-out of the new ISO IDMP (Identification of Medicinal Products) standard within Europe until after the completion of the formal Brexit processes. And yes, so far no EU Implementation Guidelines have been published and there is no need to start submitting product data and regulatory information in the new format. But whether you were skeptical about the original implementation deadlines or not, one thing remains – IDMP will still happen, with or without Brexit!
So how should you react? Is this a time to relax and enjoy some spare cycles in your day? Or is this your opportunity to be proactive and push forward with your plans knowing that IDMP is not only about regulatory standards, but also a significant opportunity for your business to improve its own internal data handling processes?
The choice is yours, but with so much to be gained these are our top five reasons for continuing at pace with your IDMP roll-out:
Kommentare
Keine Kommentare